Drug recall · May 9, 2018
Aptensio XR recall
Why: Failed Dissolution Specification: Low dissolution outside of specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45
- Lots / codes
Lot# AG8679B Exp. 01/2020
- Quantity
- 2454 bottles
- Company
- Rhodes Pharmaceuticals, L.P., Coventry, RI
- Distribution
- Nationwide within the USA
- Initiated
- April 17, 2018 · Voluntary: Firm initiated
- Classified
- May 3, 2018
- Reported
- May 9, 2018
- Ended
- May 19, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylphenidate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.